Principal oncogenic signal transduction in melanoma often engages constitutive Ras/MAPK activation and can co-involve, or recruit, dysregulated PI3K/AKT/mTOR signaling, including in the case of human and canine MM (4, 22, 45). Here, MTOR is linked to Miyoshi myopathy.